FROM THE MOUNTAINS TO THE LABS - A BRIEF SUMMARY OF THE PEOPLE AND THEIR STUDIES ON WHICH RESTS MOST OF WHAT WE KNOW TODAY

被引:2
|
作者
HOUSTON, CS [1 ]
机构
[1] COLORADO ALTITUDE RES INST, BOX 38, KEYSTONE, CO 80435 USA
关键词
HISTORY; BAROMETRIC PRESSURE; OXYGEN; HIGH ALTITUDE; MOUNTAIN SICKNESS; PATHOPHYSIOLOGY;
D O I
10.1055/s-2007-1024578
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
The science of mountain medicine is less than 150 years old, partly because mountaineering became popular only in the middle of the 19th century. In the last 30 years there has been an explosion of activity on very high mountains, in laboratories, and in simulated high altitude environments. Our knowledge and understanding of high altitude hypoxia has been built slowly and painfully over many centuries. First came recognition that pure air was essential to health. Then the physical properties of the atmosphere were demonstrated 300 years ago. Slowly the vital ingredient in air was identified, and even more recently the relationship between barometric pressure, oxygen, and the sicknesses that affect men at altitude was appreciated. In this paper, will be described how some of the most important advances were made, and where the explorers sometimes went astray. I will mention some of the people whose major contributions have been forgotten, to remind us that fame or fortune does not necessarily go to those who deserve it most. Remember that not until the middle of the 18th century did men climb high mountains. The intrepid prehistoric hunter (Otzi) who was lost on a high mountain 5000 years ago and found last year was certainly an exception. Only recently have mountaineer-scientists begun to study in the laboratory what they observed on the summits. By knowing how we came to know what we believe to be true today, perhaps we may understand better how knowledge grows, not only in a steady flow but now and then by brilliant leaps. But we will also see how much remains to be learned, and how easily we can be misled or blinded to great opportunities.
引用
收藏
页码:S6 / S9
页数:4
相关论文
共 50 条
  • [21] Fabry Disease: Switch from Enzyme Replacement Therapy to Oral Chaperone Migalastat: What Do We Know Today?
    Perretta, Fernando
    Jaurretche, Sebastian
    HEALTHCARE, 2023, 11 (04)
  • [22] Psychosis Risk and Development: What Do We Know From Population-Based Studies?
    Mennigen, Eva
    Bearden, Carrie E.
    BIOLOGICAL PSYCHIATRY, 2020, 88 (04) : 315 - 325
  • [23] Obesogenic effects of endocrine disruptors, what do we know from animal and human studies?
    de Cock, Marijke
    van de Bor, Margot
    ENVIRONMENT INTERNATIONAL, 2014, 70 : 15 - 24
  • [24] What Did We Find From Imaging Studies in Childhood Urinary Tract Infection and Which Studies Are Mandatory?
    Vachvanichsanong, Prayong
    Dissaneewate, Pornsak
    McNeil, Edward
    UROLOGY, 2018, 111 : 176 - 182
  • [25] Documenting pesticide exposures from field studies: what is known and why we should know more
    Baldi, I.
    TOXICOLOGY LETTERS, 2023, 384 : S15 - S15
  • [26] What we know about the role of corticosteroids in psychiatric disorders; evidence from animal and clinical studies
    Dabbah-Assadi, Fadwa
    Handel, Ran
    Shamir, Alon
    JOURNAL OF PSYCHIATRIC RESEARCH, 2022, 155 : 363 - 370
  • [27] Moving from 'what we know works' to 'what we do in practice': An evidence overview of implementation and diffusion of innovation in transition to adulthood for care experienced young people
    Alderson, Hayley
    Smart, Deborah
    Kerridge, Gary
    Currie, Graeme
    Johnson, Rebecca
    Kaner, Eileen
    Lynch, Amy
    Munro, Emily
    Swan, Jacky
    McGovern, Ruth
    CHILD & FAMILY SOCIAL WORK, 2023, 28 (03) : 869 - 896
  • [28] The quality of mathematics teaching from a mathematics educational perspective: what do we actually know and which questions are still open?
    Brunner, Esther
    Star, Jon R.
    ZDM-MATHEMATICS EDUCATION, 2024, 56 (05): : 775 - 787
  • [29] Respiratory Abnormalities in Parkinson's Disease: What Do We Know from Studies in Humans and Animal Models?
    Kaczynska, Katarzyna
    Orlowska, Magdalena Ewa
    Andrzejewski, Kryspin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [30] What do we know from systematic reviews about the effectiveness of assistive products for communication and information used by people with disability?
    Anttila, Heidi
    Samuelsson, Kersti
    Salminen, Anna-Liisa
    Brandt, Ase
    EVERYDAY TECHNOLOGY FOR INDEPENDENCE AND CARE, 2011, 29 : 254 - 261